Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Anna, Klukowska"'
Autor:
Anna Klukowska, Robert F. Sidonio, Guy Young, Maria Elisa Mancuso, María Teresa Álvarez-Román, Neha Bhatnagar, Martina Jansen, Sigurd Knaub
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
People with severe hemophilia A usually experience their first bleed early in life. In children with severe hemophilia A, primary prophylaxis is recommended to prevent recurrent and potentially life-threatening bleeds that significantly impact day-to
Externí odkaz:
https://doaj.org/article/4b43aa2a1eb1467da546e3af893c60c2
Autor:
Tomasz Urasiński, Klaudia Paczóska, Wanda Badowska, Halina Bobrowska, Łucja Dakowicz, Grzegorz Dobaczewski, Elżbieta Latos-Grażyńska, Grażyna Karolczyk, Anna Klukowska, Andrzej Kołtan, Magdalena Wojdalska, Paweł Łaguna, Maciej Niedźwiedzki, Danuta Pietrys, Julia Radoń-Proskura, Monika Radwańska, Iwona Rurańska, Tomasz Szczepański, Dariusz Wasiński, Irena Woźnica-Karczmarz, Karolina Zielezińska, Aleksandra Królak, Tomasz Ociepa
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
IntroductionIn 2020, the new nationwide protocol of prophylaxis in Polish plasma-derived FVIII (pdFVIII) previously treated patients (PTPs) with severe hemophilia A (sHA) was introduced, resulting in the necessity of switching from pdFVIII to recombi
Externí odkaz:
https://doaj.org/article/b937e71489a94a3f929880c7587f2bdc
Autor:
Anna Klukowska, Vladimír Komrska, Vladimír Vdovin, Nadezhda Zozulya, Toshko Lissitchkov, Johannes Oldenburg, Carmen Escuriola Ettingshausen
Publikováno v:
Therapeutic Advances in Hematology, Vol 11 (2020)
Treatment of haemophilia A with FVIII replacement has evolved over the past decades to adapt to the needs of patients. octanate®, a plasma-derived, double virus-inactivated, von Willebrand factor (VWF)-containing FVIII concentrate, has been used in
Externí odkaz:
https://doaj.org/article/b80996ddbde944fba2c48e10d46c564e
Autor:
Katarzyna Rawa, Roman J. Szczesny, Ewelina P. Owczarek, Anna Adamowicz-Salach, Anna Klukowska, Urszula Demkow, Danuta Plochocka, Pawel Szczesny, Monika Gora, Andrzej Dziembowski, Beata Burzynska
Publikováno v:
BMC Medical Genetics, Vol 18, Iss 1, Pp 1-6 (2017)
Abstract Background The thalassemia syndromes are classified according to the globin chain or chains whose production is affected. β-thalassemias are caused by point mutations or, more rarely, deletions or insertions of a few nucleotides in the β-g
Externí odkaz:
https://doaj.org/article/fc2fa0a2aaf14b5aa45fdaf66d2a68f1
Autor:
Tomasz Urasinski, Klaudia Paczoska, Wanda Badowska, Halina Bobrowska, Lucja Dakowicz, Grzegorz Dobaczewski, Elzbieta Latos-Grazynska, Grazyna Karolczyk, Anna Klukowska, Andrzej Koltan, Magdalena Wojdalska, Pawel Laguna, Maciej Niedzwiecki, Danuta Pietrys, Julia Radon-Proskura, Monika Radwanska, Iwona Ruranska, Tomasz Szczepanski, Dariusz Wasinski, Irena Woznica-Karczmarz, Tomasz Ociepa
Publikováno v:
Blood. 140:2737-2739
Autor:
Toshko Lissitchkov, Anna Klukowska, John Pasi, Craig M. Kessler, Robert Klamroth, Raina J. Liesner, Larisa Belyanskaya, Olaf Walter, Sigurd Knaub, Johann Bichler, Martina Jansen, Johannes Oldenburg
Publikováno v:
Therapeutic Advances in Hematology, Vol 10 (2019)
Simoctocog alfa (human-cl rhFVIII, Nuwiq®) is a 4th generation recombinant FVIII (rFVIII), without chemical modification or fusion with any other protein/fragment. Nuwiq® is produced in a human embryonic kidney cell line (HEK293F), which ensures hu
Externí odkaz:
https://doaj.org/article/7231c4278c1b4b3f877509384a9fb07f
Autor:
Raina Liesner, Krista Fischer, Antoine Rauch, Deepthi Jayawardene, Michael Recht, Bent Winding, Beatrice Nolan, Anna Klukowska, Sriya Gunawardena, Amy D. Shapiro, Margaret V. Ragni, Julie Curtin, Sutirtha Mukhopadhyay
Publikováno v:
Blood Adv
PUPs B-LONG evaluated the safety and efficacy of recombinant factor IX Fc fusion protein (rFIXFc) in previously untreated patients (PUPs) with hemophilia B. In this open-label, phase 3 study, male PUPs (age 85%) bleeding episodes required only 1 infu
Autor:
Anna Weronska, Anna Klukowska, Marguerite Neerman-Arbez, Jacek Treliński, Anetta Undas, Ewa Wypasek
Publikováno v:
Polish archives of internal medicine. 132(7-8)
Autor:
Wojciech Młynarski, Jerzy Windyga, Paweł Łaguna, Tomasz Urasiński, Jacek Musiał, Andrzej Mital, Anna Klukowska, Magdalena Łętowska, Krzysztof Chojnowski, Jacek Treliński, Joanna Zdziarska, Anetta Undas, Maria Podolak-Dawidziak
Publikováno v:
Journal of Transfusion Medicine. 13:165-175
In this document, the Group for Haemostasis of the Polish Society of Haematology and Transfusion Medicine presents the guidelines for the use of emicizumab. Emicizumab (Hemlibra®, F. Hoffmann — La Roche, Basel, Switzerland) has been licensed for u
Autor:
Piotr Skrzypczyk, Michał Brzewski, Anna Klukowska, Grażyna Krzemień, Magdalena Kowalewska-Młot, Małgorzata Pańczyk-Tomaszewska
Publikováno v:
Central-European Journal of Immunology
Introduction Perinatal period is characterized by an increased risk of thrombosis due to low resources and limited compensatory capacity of the coagulation system in early stages of life. Case report We report a case of a second pregnancy female infa